US Stock MarketDetailed Quotes
ISPC iSpecimen
- 2.870
- -0.030-1.03%
Close Jan 8 16:00 ET
- 2.835
- -0.035-1.22%
Post 17:24 ET
2.76MMarket Cap-0.16P/E (TTM)
2.920High2.810Low45.10KVolume2.900Open2.900Pre Close128.47KTurnover5.30%Turnover RatioLossP/E (Static)962.64KShares11.80052wk High0.59P/B2.44MFloat Cap2.62252wk Low--Dividend TTM850.99KShs Float579.598Historical High--Div YieldTTM3.79%Amplitude2.621Historical Low2.848Avg Price1Lot Size
About iSpecimen Company
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.
Company Profile
SymbolISPC
Company NameiSpecimen
Listing DateJun 17, 2021
Issue Price8.00
Founded2009
CEOMr. Robert Bradley Lim
MarketNASDAQ
Employees53
Fiscal Year Ends12-31
Address8 Cabot Road,Suite 1800
CityWoburn
ProvinceMassachusetts
CountryUnited States of America
Zip Code01801
Phone1-781-301-6700
Websitehttp://www.ispecimen.com
Company Executives
- Name
- Position
- Salary
- Robert Bradley Lim
- Director, Chief Executive Officer, Treasurer and Secretary
- --
- Yuying Liang
- Chief Financial Officer
- --
- Katharyn Field
- Chairman of the Board
- --
- John L. Brooks, III
- Independent Director
- 34.93K
- Richard Paolone
- Independent Director
- --
- George Scholl
- Independent Director
- --
- Avtar Dhaliwal
- Independent Director
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data